{"id":"https://openalex.org/W4361882835","doi":"https://doi.org/10.1158/1078-0432.22450223","title":"Supplementary Figure 1 from Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)","display_name":"Supplementary Figure 1 from Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361882835","doi":"https://doi.org/10.1158/1078-0432.22450223"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22450223","doi":"https://doi.org/10.1158/1078-0432.22450223","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22450223","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Tumor_Genetic_Analyses_of_Patients_with_Metastatic_Melanoma_Treated_with_the_BRAF_Inhibitor_Dabrafenib_GSK2118436_/22450223/1/files/39901289.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Tumor_Genetic_Analyses_of_Patients_with_Metastatic_Melanoma_Treated_with_the_BRAF_Inhibitor_Dabrafenib_GSK2118436_/22450223/1/files/39901289.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072490052","display_name":"Katherine L. Nathanson","orcid":"https://orcid.org/0000-0002-6740-0901","observed_orcids":["https://orcid.org/0000-0002-6740-0901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine L. Nathanson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070535554","display_name":"Anne\u2010Marie Martin","orcid":"https://orcid.org/0000-0001-6446-7791","observed_orcids":["https://orcid.org/0000-0001-6446-7791","https://orcid.org/0009-0005-6678-8835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne-Marie Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048503160","display_name":"Bradley Stephen Wubbenhorst","orcid":"https://orcid.org/0000-0001-8489-3659","observed_orcids":["https://orcid.org/0000-0001-8489-3659"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradley Wubbenhorst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051856148","display_name":"Joel D. Greshock","orcid":"https://orcid.org/0000-0001-6567-4266","observed_orcids":["https://orcid.org/0000-0001-6567-4266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joel Greshock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077092722","display_name":"Richard Letrero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Letrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090652107","display_name":"Kurt P D'Andrea","orcid":"https://orcid.org/0000-0001-7005-3800","observed_orcids":["https://orcid.org/0000-0001-7005-3800"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kurt D'Andrea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060495866","display_name":"Steven J O'Day","orcid":"https://orcid.org/0009-0005-5345-5417","observed_orcids":["https://orcid.org/0009-0005-5345-5417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven O'Day","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103514741","display_name":"Jeffrey R. Infante","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey R. Infante","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069777765","display_name":"Gerald Steven Falchook","orcid":"https://orcid.org/0000-0001-9165-2191","observed_orcids":["https://orcid.org/0000-0001-9165-2191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald S. Falchook","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012989377","display_name":"Hendrik\u2010Tobias Arkenau","orcid":"https://orcid.org/0000-0002-2015-1549","observed_orcids":["https://orcid.org/0000-0002-2015-1549","https://orcid.org/0000-0003-0372-0540"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hendrik-Tobias Arkenau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111060479","display_name":"Michael J. Millward","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Millward","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021075431","display_name":"Michael Paul Brown","orcid":"https://orcid.org/0000-0002-5796-1932","observed_orcids":["https://orcid.org/0000-0002-5796-1932","https://orcid.org/0000-0002-0495-7315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael P. Brown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056507476","display_name":"Anna C. Pavlick","orcid":"https://orcid.org/0000-0001-7088-0742","observed_orcids":["https://orcid.org/0000-0001-7088-0742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Pavlick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100736388","display_name":"Bo Ma","orcid":"https://orcid.org/0000-0003-4948-4897","observed_orcids":["https://orcid.org/0000-0003-4948-4897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bo Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076775426","display_name":"Robert J. Gagnon","orcid":"https://orcid.org/0009-0001-7339-3795","observed_orcids":["https://orcid.org/0009-0001-7339-3795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Gagnon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046016127","display_name":"Martin Curtis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Curtis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061657442","display_name":"Peter F. Lebowitz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter F. Lebowitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062978331","display_name":"Richard F. Kefford","orcid":"https://orcid.org/0000-0001-9251-9229","observed_orcids":["https://orcid.org/0000-0001-9251-9229"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Kefford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Georgina V. Long","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.9390000104904175},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.9309999942779541},{"id":"https://openalex.org/keywords/progressive-disease","display_name":"progressive disease","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.7842462658882141},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.7808841466903687},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5773227214813232},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5717635750770569},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5344151258468628},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5306738018989563},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.45115718245506287},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4043797254562378},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.31266504526138306},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.1663314402103424}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22450223","doi":"https://doi.org/10.1158/1078-0432.22450223","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22450223","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Tumor_Genetic_Analyses_of_Patients_with_Metastatic_Melanoma_Treated_with_the_BRAF_Inhibitor_Dabrafenib_GSK2118436_/22450223/1/files/39901289.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22450223.v1","doi":"https://doi.org/10.1158/1078-0432.22450223.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22450223.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22450223","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Tumor_Genetic_Analyses_of_Patients_with_Metastatic_Melanoma_Treated_with_the_BRAF_Inhibitor_Dabrafenib_GSK2118436_/22450223","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22450223","doi":"https://doi.org/10.1158/1078-0432.22450223","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22450223","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Tumor_Genetic_Analyses_of_Patients_with_Metastatic_Melanoma_Treated_with_the_BRAF_Inhibitor_Dabrafenib_GSK2118436_/22450223/1/files/39901289.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361882835.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361908211","https://openalex.org/W4361959557","https://openalex.org/W2110764732","https://openalex.org/W7099570191","https://openalex.org/W2167059308","https://openalex.org/W2316368416","https://openalex.org/W4220697272","https://openalex.org/W2966829998","https://openalex.org/W2607030170","https://openalex.org/W2603101818"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"1":[2],"-":[3],"PDF":[4],"file":[5],"214K,":[6],"Copy":[7],"number":[8],"in":[9],"baseline":[10],"samples":[11],"from":[12],"patients":[13],"with":[14,20],"partial":[15],"response":[16],"compared":[17],"to":[18],"those":[19],"stable":[21],"or":[22],"progressive":[23],"disease":[24]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}